Biofrontera AG (ETR:B8FK)
Germany
· Delayed Price · Currency is EUR 2.550
-0.060 (-2.30%)
At close: May 12, 2025, 5:30 PM CET
Biofrontera AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 21.67 | 32.25 | 25.74 | 28.79 | 30.35 | Upgrade
|
| Other Revenue | - | -0 | - | - | - | Upgrade
|
| Revenue | 21.67 | 32.25 | 25.74 | 28.79 | 30.35 | Upgrade
|
| Revenue Growth (YoY) | -32.81% | 25.29% | -10.59% | -5.14% | -2.94% | Upgrade
|
| Cost of Revenue | 5.33 | 6.24 | 4.76 | 3.91 | 3.54 | Upgrade
|
| Gross Profit | 16.34 | 26.01 | 20.98 | 24.87 | 26.81 | Upgrade
|
| Selling, General & Admin | 16.93 | 13.38 | 12.26 | 33.75 | 27.63 | Upgrade
|
| Research & Development | 5.35 | 7.85 | 7.13 | 7.01 | 4.79 | Upgrade
|
| Operating Expenses | 22.28 | 21.22 | 19.39 | 40.76 | 32.42 | Upgrade
|
| Operating Income | -5.94 | 4.78 | 1.59 | -15.88 | -5.61 | Upgrade
|
| Interest Expense | -0.01 | -0.02 | -0.16 | -3.72 | -3.08 | Upgrade
|
| Interest & Investment Income | 0.06 | 0.02 | 0 | 0.01 | 0.41 | Upgrade
|
| Earnings From Equity Investments | -1.3 | -7.26 | -44.17 | 14.73 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.01 | -0.68 | 0.16 | -3.6 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.47 | 0.36 | 0.21 | 0.67 | 1.18 | Upgrade
|
| EBT Excluding Unusual Items | -6.72 | -2.13 | -43.21 | -4.04 | -10.7 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 59.18 | - | Upgrade
|
| Asset Writedown | - | - | - | - | -2 | Upgrade
|
| Legal Settlements | - | - | - | -19.46 | - | Upgrade
|
| Pretax Income | -6.72 | -2.13 | -43.21 | 35.68 | -12.7 | Upgrade
|
| Income Tax Expense | -2.37 | -1.76 | 0.96 | 1.83 | 0.33 | Upgrade
|
| Earnings From Continuing Operations | -4.35 | -0.37 | -44.17 | 33.86 | -13.02 | Upgrade
|
| Minority Interest in Earnings | - | - | - | 4.46 | - | Upgrade
|
| Net Income | -4.35 | -0.37 | -44.17 | 38.32 | -13.02 | Upgrade
|
| Net Income to Common | -4.35 | -0.37 | -44.17 | 38.32 | -13.02 | Upgrade
|
| Shares Outstanding (Basic) | 6 | 3 | 3 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 3 | 3 | 3 | 3 | Upgrade
|
| Shares Change (YoY) | 100.00% | 11.02% | 1.34% | 4.68% | 21.23% | Upgrade
|
| EPS (Basic) | -0.72 | -0.12 | -16.14 | 14.53 | -5.05 | Upgrade
|
| EPS (Diluted) | -0.72 | -0.21 | -16.17 | 14.28 | -5.05 | Upgrade
|
| Free Cash Flow | -2.75 | -2.82 | -4.88 | 29.81 | -3.62 | Upgrade
|
| Free Cash Flow Per Share | -0.45 | -0.93 | -1.78 | 11.04 | -1.40 | Upgrade
|
| Gross Margin | 75.41% | 80.64% | 81.52% | 86.41% | 88.35% | Upgrade
|
| Operating Margin | -27.43% | 14.83% | 6.18% | -55.17% | -18.49% | Upgrade
|
| Profit Margin | -20.08% | -1.14% | -171.60% | 133.11% | -42.91% | Upgrade
|
| Free Cash Flow Margin | -12.69% | -8.73% | -18.95% | 103.55% | -11.94% | Upgrade
|
| EBITDA | -5.7 | 4.99 | 1.78 | -15.6 | -5.33 | Upgrade
|
| EBITDA Margin | -26.31% | 15.49% | 6.91% | -54.20% | -17.57% | Upgrade
|
| D&A For EBITDA | 0.24 | 0.21 | 0.19 | 0.28 | 0.28 | Upgrade
|
| EBIT | -5.94 | 4.78 | 1.59 | -15.88 | -5.61 | Upgrade
|
| EBIT Margin | -27.43% | 14.83% | 6.18% | -55.17% | -18.49% | Upgrade
|
| Effective Tax Rate | - | - | - | 5.12% | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.